Target intelligence / Profile preview

Immunoglobulin kappa variable 3D-20 (IGKV3D-20)

Target
IGKV3D-20
Molecular classification
Immunoglobulin variable domain, Immunoglobulin kappa light chain, Immunoglobulin superfamily, Other (Variable domain; not a receptor or enzyme)
01

Overview

Immunoglobulin kappa variable 3D-20 is the variable domain of the kappa light chain in human antibodies, encoded by the IGKV3D-20 gene. It contributes to the specificity and diversity of immunoglobulin molecules by participating in antigen recognition, forming part of the antigen-binding site along with heavy chain variable domains. The variable domains are generated by V-(D)-J recombination and somatic hypermutation processes during B cell development, enabling affinity maturation. This domain is integral to humoral immunity, as it enables B lymphocytes to generate antibodies capable of binding to a vast array of antigens, including pathogens and abnormal self molecules. While the diversity of immunoglobulin variable domains is crucial for immune response, IGKV3D-20 itself is not a direct therapeutic target; instead, it represents one of many immunoglobulin gene segments contributing to antibody repertoire[5][3][2][11].

Other names
IGKV3D-20Immunoglobulin kappa variable 3D-20A11A11aIGKV3D20KVD20 protein
02

Biological functions

Antigen bindingHumoral immune responseAntibody diversityAntigen recognition
03

Disease associations

Cancer (expression/involvement in B-cell malignancies, immunoglobulin abnormalities)Infection (central to antibody-mediated pathogen neutralization)Other (autoimmunity and immunodeficiency)

Beyond the preview

Go deeper on Immunoglobulin kappa variable 3D-20 (IGKV3D-20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin kappa variable 3D-20 (IGKV3D-20).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call